 |
The BioCentury ShowAuthor: BioCentury
The BioCentury Show is where biopharma executives, investors and policy markers discuss how to turn science into medicine. Don't miss this twice-monthly conversation with BioCentury editors. Available for free via webcast or podcast. Visit http://biocenturyshow.com/ to learn more. Language: en-us Genres: Business, Life Sciences, Science Contact email: Get it Feed URL: Get it iTunes ID: Get it |
Listen Now...
Ep. 59 - Derek Lowe Unplugged: AI; Biosecure; FDA, Abortion & SCOTUS; and more
Episode 59
Thursday, 16 May, 2024
“I’m a short-term pessimist and a long-term optimist” about the potential for AI to transform drug development, Derek Lowe, author of the In the Pipeline blog, told BioCentury Washington Editor Steve Usdin on the latest BioCentury Show. Lowe's skepticism about claims that AI will rapidly transform the field is driven by a belief that the “problems that we have in the drug industry that we want to solve are almost inversely proportional to the ability of AI to solve them." Lowe also discussed the Biosecure Act and U.S. reliance on Chinese contract manufacturing and development organizations; talked about why he hopes and believes the Supreme Court will rule for FDA in litigation over the abortion drug mifepristone; and explained his view that approval of Aduhelm to treat Alzheimer’s disease was one of FDA’s worst decisions View full story: https://www.biocentury.com/article/652427#biotech #biopharma #pharma #lifescience #DrugDiscovery00:00 - Intro 01:04 - Lowe’s Blog04:42 - Biosecure Act09:04 - AI & Drug Discovery16:46 - FDA, The Abortion Drug, & Aduhelm
